We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pomegranate Juice Lowers Cardiovascular Risk in Dialysis Patients

By HospiMedica International staff writers
Posted on 13 Dec 2011
Hemodialysis patients had significant improvement in their cardiovascular risk (CV) profile after consuming 300 cc of pomegranate juice weekly for a year, according to a new study. More...


Researchers at the Western Galilee Hospital (WGH; Nahariya, Israel) conducted a randomized, placebo-controlled clinical trial involving 101 hemodialysis patients randomized on a 2:1 ratio to receive 100 cc of pomegranate juice three times weekly, or a matching placebo. The primary endpoints were change in lipid profile--triglycerides, low-density lipoprotein (LDL), and high-density lipoprotein (HDL)--and change in blood pressure (systolic, diastolic, and number of medications). Subsequently, 26 patients in the placebo group and 41 in the pomegranate arm completed the 12-month study.

The results showed that triglyceride levels and systolic blood pressure declined significantly from baseline, and high-density lipoprotein (HDL) increased significantly; diastolic blood pressure did not change significantly in either group. In addition, consumption of pomegranate juice on a regular basis was associated with a 22.2% reduction in use of antihypertensive medications. In contrast, patients randomized to placebo had no significant changes in any of the parameters. The study was presented at the American Society of Nephrology (ASN) annual meeting, held during November 2011 in Philadelphia (PA, USA).

“Ongoing regular consumption of pomegranate juice may well lead to improved quality of life by reducing the high illness rate among dialysis patients,” said lead author and study presenter Batya Kristal, MD. “In the pomegranate arm, the parameters that improved did so within the first three months of the study, and either remained stable or continued to increase to the end of the trial.”

Pomegranate has a history of association with health benefits dating back to ancient times, ranging from improvement in various gastrointestinal (GI) conditions to ameliorating headaches associated with a hangover. There is evidence of antiviral, antibacterial, anti-inflammatory, and anticarcinogenic potential for pomegranate, as well as improvement in lipid profile, blood pressure, and heart function in patients with diabetes, hypertension, and heart disease. A possible explanation for the benefits is that pomegranate juice contains substantial concentrations of ascorbic and polyphenolic acids, and that pomegranate peel and pulp have large concentrations of antioxidants.

Related Links:
Western Galilee Hospital



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
New
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.